These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 39046176

  • 1. Lymph node metastasis in early invasive lung adenocarcinoma: Prediction model establishment and validation based on genomic profiling and clinicopathologic characteristics.
    Guo W, Lu T, Song Y, Li A, Feng X, Han D, Cao Y, Sun D, Gong X, Li C, Jin R, Du H, Chen K, Xiang J, Hang J, Chen G, Li H.
    Cancer Med; 2024 Jul; 13(14):e70039. PubMed ID: 39046176
    [Abstract] [Full Text] [Related]

  • 2. A liquid biopsy assay for the noninvasive detection of lymph node metastases in T1 lung adenocarcinoma.
    Li X, Gu Y, Hu B, Shao MM, Li H.
    Thorac Cancer; 2024 Jun; 15(16):1312-1319. PubMed ID: 38682829
    [Abstract] [Full Text] [Related]

  • 3. Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas.
    Das SK, Fang KW, Xu L, Li B, Zhang X, Yang HF.
    Sci Rep; 2021 May 24; 11(1):10829. PubMed ID: 34031529
    [Abstract] [Full Text] [Related]

  • 4. Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status.
    Ricciuti B, Arbour KC, Lin JJ, Vajdi A, Vokes N, Hong L, Zhang J, Tolstorukov MY, Li YY, Spurr LF, Cherniack AD, Recondo G, Lamberti G, Wang X, Venkatraman D, Alessi JV, Vaz VR, Rizvi H, Egger J, Plodkowski AJ, Khosrowjerdi S, Digumarthy S, Park H, Vaz N, Nishino M, Sholl LM, Barbie D, Altan M, Heymach JV, Skoulidis F, Gainor JF, Hellmann MD, Awad MM.
    J Thorac Oncol; 2022 Mar 24; 17(3):399-410. PubMed ID: 34740862
    [Abstract] [Full Text] [Related]

  • 5. Major challenges in accurate mutation detection of multifocal lung adenocarcinoma by next-generation sequencing.
    Qiu T, Li W, Zhang F, Wang B, Ying J.
    Cancer Biol Ther; 2020 Mar 24; 21(2):170-177. PubMed ID: 31651223
    [Abstract] [Full Text] [Related]

  • 6. Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing.
    Yang H, Wen L, Pan Y, Shan C, Hong W, Wang H, Zhou C, Cai L, Zhou C.
    BMC Cancer; 2022 May 25; 22(1):580. PubMed ID: 35614407
    [Abstract] [Full Text] [Related]

  • 7. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
    Shi J, Hua X, Zhu B, Ravichandran S, Wang M, Nguyen C, Brodie SA, Palleschi A, Alloisio M, Pariscenti G, Jones K, Zhou W, Bouk AJ, Boland J, Hicks B, Risch A, Bennett H, Luke BT, Song L, Duan J, Liu P, Kohno T, Chen Q, Meerzaman D, Marconett C, Laird-Offringa I, Mills I, Caporaso NE, Gail MH, Pesatori AC, Consonni D, Bertazzi PA, Chanock SJ, Landi MT.
    PLoS Med; 2016 Dec 25; 13(12):e1002162. PubMed ID: 27923066
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological significance of mutation profile detected by next generation sequencing in different metastatic organs of non-small cell lung cancers.
    Akın D, Kahraman Çeti N N, Erdoğdu İH, Öztürk H, Meteoğlu İ.
    Pathol Res Pract; 2024 Aug 25; 260():155463. PubMed ID: 39013258
    [Abstract] [Full Text] [Related]

  • 9. Molecular diagnostic characteristics based on the next generation sequencing in lung cancer and its relationship with the expression of PD-L1.
    Liu J, Liu Y.
    Pathol Res Pract; 2020 Feb 25; 216(2):152797. PubMed ID: 31926773
    [Abstract] [Full Text] [Related]

  • 10. Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
    Lim SM, Kim EY, Kim HR, Ali SM, Greenbowe JR, Shim HS, Chang H, Lim S, Paik S, Cho BC.
    Oncotarget; 2016 Apr 26; 7(17):24172-8. PubMed ID: 26992220
    [Abstract] [Full Text] [Related]

  • 11. Concomitant genomic alterations in KRAS mutant advanced lung adenocarcinoma.
    Gibert J, Clavé S, Hardy-Werbin M, Taus Á, Rocha P, Longarón R, Piquer G, Chaib I, Carcereny E, Morán T, Salido M, Dalmases A, Bellosillo B, Arriola E.
    Lung Cancer; 2020 Feb 26; 140():42-45. PubMed ID: 31862576
    [Abstract] [Full Text] [Related]

  • 12. A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma.
    Jones GD, Brandt WS, Shen R, Sanchez-Vega F, Tan KS, Martin A, Zhou J, Berger M, Solit DB, Schultz N, Rizvi H, Liu Y, Adamski A, Chaft JE, Riely GJ, Rocco G, Bott MJ, Molena D, Ladanyi M, Travis WD, Rekhtman N, Park BJ, Adusumilli PS, Lyden D, Imielinski M, Mayo MW, Li BT, Jones DR.
    JAMA Surg; 2021 Feb 01; 156(2):e205601. PubMed ID: 33355651
    [Abstract] [Full Text] [Related]

  • 13. Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma.
    Wu C, Rao X, Lin W.
    Cancer Med; 2021 Feb 01; 10(3):806-823. PubMed ID: 33314730
    [Abstract] [Full Text] [Related]

  • 14. Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma.
    Zhou J, Sanchez-Vega F, Caso R, Tan KS, Brandt WS, Jones GD, Yan S, Adusumilli PS, Bott M, Huang J, Isbell JM, Sihag S, Molena D, Rusch VW, Chatila WK, Rekhtman N, Yang F, Ladanyi M, Solit DB, Berger MF, Schultz N, Jones DR.
    Clin Cancer Res; 2019 Dec 15; 25(24):7475-7484. PubMed ID: 31455678
    [Abstract] [Full Text] [Related]

  • 15. Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing.
    Chun YJ, Choi JW, Hong MH, Jung D, Son H, Cho EK, Min YJ, Kim SW, Park K, Lee SS, Kim S, Kim HR, Cho BC, Korean Lung Cancer Consortium (KLCC).
    PLoS One; 2019 Dec 15; 14(11):e0224379. PubMed ID: 31765373
    [Abstract] [Full Text] [Related]

  • 16. A genomic-clinicopathologic Nomogram for the preoperative prediction of lymph node metastasis in gastric cancer.
    Zhong X, Xuan F, Qian Y, Pan J, Wang S, Chen W, Lin T, Zhu H, Wang X, Wang G.
    BMC Cancer; 2021 Apr 23; 21(1):455. PubMed ID: 33892676
    [Abstract] [Full Text] [Related]

  • 17. The role of adenocarcinoma subtypes and immunohistochemistry in predicting lymph node metastasis in early invasive lung adenocarcinoma.
    Xue M, Liu J, Li Z, Lu M, Zhang H, Liu W, Tian H.
    BMC Cancer; 2024 Jan 29; 24(1):139. PubMed ID: 38287300
    [Abstract] [Full Text] [Related]

  • 18. Decoding tumor mutation burden and driver mutations in early stage lung adenocarcinoma using CT-based radiomics signature.
    Wang X, Kong C, Xu W, Yang S, Shi D, Zhang J, Du M, Wang S, Bai Y, Zhang T, Chen Z, Ma Z, Wang J, Dong G, Sun M, Yin R, Chen F.
    Thorac Cancer; 2019 Oct 29; 10(10):1904-1912. PubMed ID: 31414580
    [Abstract] [Full Text] [Related]

  • 19. KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to Immunotherapy.
    Scalera S, Mazzotta M, Corleone G, Sperati F, Terrenato I, Krasniqi E, Pizzuti L, Barba M, Vici P, Gallo E, Buglioni S, Visca P, Pescarmona E, Marinelli D, De Nicola F, Ciuffreda L, Goeman F, Fanciulli M, Giusti R, Vecchione A, De Maria R, Cappuzzo F, Marchetti P, Ciliberto G, Maugeri-Saccà M.
    J Thorac Oncol; 2021 Dec 29; 16(12):2065-2077. PubMed ID: 34450259
    [Abstract] [Full Text] [Related]

  • 20. Distinctive targetable genotypes of younger patients with lung adenocarcinoma: a cBioPortal for cancer genomics data base analysis.
    Hou H, Zhang C, Qi X, Zhou L, Liu D, Lv H, Li T, Sun D, Zhang X.
    Cancer Biol Ther; 2020 Dec 29; 21(1):26-33. PubMed ID: 31594446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.